Emtee 25mcg Tablet
Product introduction
Emtee 25mcg Tablet is given alone or in combination with some other medicine to attain the maximum benefit. It should be taken with food or as your doctor's advice. It should be taken orally, by swallow the tablets whole with a drink of water. If you experience vomiting within 30 minutes of tablet intake, inform your doctor or take another tablet. The medicine may take 24 hours to show its action and you experience bleeding.
Common side effects of this medicine include infection following abortion, nausea, vomiting, diarrhea, cramps, uterine contractions or cramping, uterine bleeding, heavy bleeding, and fetal malformations. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Usually, vaginal bleeding may last for 12 days, inform your doctor if it lasts for more than 12 days or you notice severe abdominal pain.
Before taking this medicine, tell your doctor if you have ever had an ectopic pregnancy, or you are breastfeeding or using an intrauterine device. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. You must avoid strenuous activity like heavy exercise, running, and driving while abortion as it can affect the bleeding. Your doctor may perform an ultrasound or pelvic examination to check for abortion completion.
Uses of Emtee Tablet
- Medical abortion
- Post-delivery bleeding
Side effects of Emtee Tablet
Common side effects of Emtee
- Nausea
- Dyspepsia
- Vomiting
- Flatulence
- Constipation
- Uterine bleeding
- Diarrhea
- Cramps
- Abdominal pain
How to use Emtee Tablet
How Emtee Tablet works
Safety advice
However, inform your doctor if you have an underlying kidney disease. This medicine may be started with a low dose and then increased with caution by your doctor.
What if you forget to take Emtee Tablet?
All substitutes
Quick tips
- Emtee 25mcg Tablet helps terminate pregnancy when used along with another medicine called mifepristone.
- It may also be used to prevent excessive bleeding after delivery.
- For pregnancy termination:
- Take it no later than 63 days after the first day of your last menstrual period.
- Take it 36 – 48 hours after taking mifepristone.
- Rest for at least 3 hours after taking the medicine.
- If you vomit within 30 minutes of taking the tablet, talk to your doctor immediately, as you may need to take another tablet.
- Take it only as prescribed by the doctor. Miscarriages, if incomplete, may result in serious medical complications leading to hospitalization, surgery and possible infertility.
- Vaginal bleeding lasting for approximately 12 days may occur after taking this medicine. Inform your doctor immediately if excessive bleeding occurs or if you suffer from severe abdominal pain.
- Use caution while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.
- It does not affect fertility. Use contraception to avoid pregnancy.
Fact Box
Patient concerns
FAQs
What is Emtee 25mcg Tablet and what is used for?
How and in what dose should I take Emtee 25mcg Tablet?
What should I expect after taking Emtee 25mcg Tablet?
Can Emtee 25mcg Tablet affect my future chances of getting pregnant?
What are the common side effects of taking Emtee 25mcg Tablet?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Schimmer BP, Parker KL. Contraception and Pharmacotherapy of Obstetrical and Gynecological Disorders. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1850.
- Smyth EM, FitzGerald GA. The Eicosanoids: Prostaglandins, Tromboxanes, Leukotriens, & Related Compounds. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 315.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 927-31.